How State And Federal Policies As Well As Advances In Genome Science Contribute To The High Cost Of Cancer Drugs-Reference-Cited by-同舟云学术

How State And Federal Policies As Well As Advances In Genome Science Contribute To The High Cost Of Cancer Drugs

Published:2015-04 Issue:4 Volume:34 Page:571-575
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Ramsey Scott D.¹

Affiliation:

1. Scott D. Ramsey ( ) is director of the Hutchinson Institute for Cancer Outcomes Research (HICOR), at the Fred Hutchinson Cancer Research Center, in Seattle, Washington.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference18 articles.

1. How Should We Pay the Piper When He's Calling the Tune? On the Long-Term Affordability of Cancer Care in the United States

2. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

3. American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care

4. The Price Tag on Progress — Chemotherapy for Colorectal Cancer

5. Drug Pricing and Value in Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030;JNCI Cancer Spectrum;2021-07-06

2. The Effect of Market Competition on the Price of Topical Eye Drops;Seminars in Ophthalmology;2021-03-29

3. Lessons From The Impact Of Price Regulation On The Pricing Of Anticancer Drugs In Germany;Health Affairs;2020-07-01

4. The Complex Cancer Care Coverage Environment — What is the Role of Legislation?;Journal of Law, Medicine & Ethics;2020

5. Competition and price among brand-name drugs in the same class: A systematic review of the evidence;PLOS Medicine;2019-07-30